ViaLase announced the first patient has been treated in its US-based Investigational Device Exemption (IDE) clinical trial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback